Home

VeriTeQ'S advanced Technology Helps Device Manufacturers, Physicians and Patients

VeriTeQ develops innovative, FDA cleared, radio frequency identification (RFID) solutions to identify implantable medical devices, FDA cleared radiation dose measurement technologies, and future bio-sensing applications.

VeriTeQ’s Chairman and CEO, Scott R. Silverman, and Board Member, Daniel E. Penni, Purchase Collectively more than 11 Million Shares of the Company’s Stock at Market Price

DELRAY BEACH, FL – April 23, 2015 – VeriTeQ Corporation (“VeriTeQ” or the “Company”) (OTC Markets: VTEQ), a provider of…
Read Article

Most Recent

Apr 16th

VeriTeQ Files its 10-K and Announces 2014 Highlights

VeriTeQ commercially launched its Q Inside Safety Technology and delivered…
Read Article

Apr 13th

VeriTeQ Corporation Expands Intellectual Property Portfolio with Patent…

VeriTeQ seeks patent protection for its High-Temperature Q Inside Safety…
Read Article

Mar 12th

LARGEST PROVIDER OF COSMETIC SURGERY IN THE UK…

The Hospital Group operates a network of more than 20…
Read Article

Feb 11th

VeriTeQ Executes Term Sheet for Exclusive License of…

Licensee will have 24-month option to purchase Q Inside Safety…
Read Article

Feb 10th

VeriTeQ Corporation Announces Reverse Stock Split

Company to trade as VTEQD for 20 trading days DELRAY…
Read Article

Jan 13th

VeriTeQ and Logic PD Building Digital Health Solutions…

VeriTeQ’s Q Inside Safety Technology to Act as Gateway to…
Read Article